New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
09:09 EDTKOOLCesca Therapeutics, Cook Medical enter supply agreement for Phase 1b trial
Cesca Therapeutics announced today that they have entered a supply agreement with Cook Medical. Under the terms of the agreement, Cook Medical has been chosen as the supplier for select delivery device products for the Acute Myocardial Infarction Rapid Stem cell Therapy, or AMIRST, Phase 1b trial set to begin later this calendar year. The clinical trial is for targeted marketing approval in the United States, European Union Community and India.
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2016
06:11 EDTKOOLTexas Stem Cell to use Cesca's AutoXpress AXP technology
Cesca Therapeutics announced that Texas Stem Cell has committed to utilizing Cesca's AutoXpress AXP technology for its cord blood banking business. The AXP platform includes a 'smart' processing device and sterile disposable that automatically concentrates the stem cells from a cord blood unit in less than one hour and delivers them directly into Cesca's patented sample bag which is optimized for cryopreservation and storage.
February 3, 2016
09:04 EDTKOOLCesca Therapeutics announces $15M strategic investment from Boyalife Group
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use